We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Intersect ENT, Inc in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 126 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 131 → 0 (-131)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $826M → $0 (-$826M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 126

Holders
–
Holders Change
-131
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
126
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VI
Versor Investments
New York
-$93.1M
2
BlackRock
BlackRock
New York
-$73.7M
3
MF
Magnetar Financial
Illinois
-$71.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$48.7M
5
AAM
Alpine Associates Management
Florida
-$38.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AGM
51
Alpine Global Management
New York
– -$2.8K -100,000 Closed
Canada Pension Plan Investment Board
52
Canada Pension Plan Investment Board
Ontario, Canada
– -$2.63M -94,000 Closed
Ohio Public Employees Retirement System (OPERS)
53
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$2.52M -90,000 Closed
SC
54
Sarissa Consulting
California
– -$2.51M -89,745 Closed
GI
55
GAMCO Investors
Connecticut
– -$2.37M -84,434 Closed
CS
56
Credit Suisse
Switzerland
– -$2.18M -77,918 Closed
WMSA
57
Weiss Multi-Strategy Advisers
New York
– -$2.12M -75,569 Closed
Swiss National Bank
58
Swiss National Bank
Switzerland
– -$2.11M -75,200 Closed
BPGAM
59
BTG Pactual Global Asset Management
Bermuda
– -$2.1M -74,785 Closed
SMC
60
S. Muoio & Co
New York
– -$1.74M -62,000 Closed
D.E. Shaw & Co
61
D.E. Shaw & Co
New York
– -$1.39M -49,605 Closed
Dimensional Fund Advisors
62
Dimensional Fund Advisors
Texas
– -$1.33M -47,480 Closed
ECM
63
ExodusPoint Capital Management
New York
– -$1.21M -43,152 Closed
RJA
64
Raymond James & Associates
Florida
– -$1.2M -42,713 Closed
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
– -$1.16M -41,545 Closed
GC
66
Guggenheim Capital
Illinois
– -$1.09M -39,091 Closed
CL
67
CSS LLC
Illinois
– -$1.08M -38,524 Closed
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
– -$993K -35,439 Closed
Verition Fund Management
69
Verition Fund Management
Connecticut
– -$971K -34,673 Closed
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
– -$918K -32,756 Closed
SO
71
STRS Ohio
Ohio
– -$910K -32,500 Closed
Susquehanna International Group
72
Susquehanna International Group
Pennsylvania
– -$866K -30,917 Closed
Allianz Asset Management
73
Allianz Asset Management
Germany
– -$840K -30,000 Closed
Skandinaviska Enskilda Banken (SEB)
74
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$827K -29,511 Closed
UBS AM
75
UBS AM
Illinois
– -$820K -29,267 Closed
1 2
3
4 5

XENT Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2022, worth a combined $0 — down 100% from $826M a quarter earlier.

Sellers outnumbered buyers: 126 funds closed out of XENT and 0 opened new positions — a net loss of 126 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Versor Investments, exiting entirely with an estimated $93.1M sold.

  • 0 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2022, down from 131 in Q1 2022.
  • Funds reported $0 of Intersect ENT, Inc stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Intersect ENT, Inc positions in Q2 2022 and 126 closed out, a net change of -126 holders.
  • The largest Intersect ENT, Inc seller in Q2 2022 was Versor Investments, an estimated $93.1M sold.

Based on aggregated 13F filings for Q2 2022.